Samra LİAQAT, Muhammad ISLAM, Hamid SAEED, Mehwish IQTEDAR, Azra MEHMOOD

Investigation of Olea ferruginea Roylebark extracts for potential in vitro antidiabetic and anticancer effects

This study was conducted to investigate the physicochemical, phytochemical, in vitro antidiabetic and anticancer potential of Olea ferruginea R bark. After extraction using Soxhlet, in vitro antidiabetic and cytotoxic activity on human hepatocellular carcinoma (HepG2) cells was assessed by nonenzymatic glycosylation of hemoglobin assay, alpha-amylase inhibition assay, glucose uptake by yeast cells, and 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide assay, respectively, and gene expression via real-time polymerase chain reaction. Primary and secondary metabolites were present in the extractants; polyphenols (35.61 +/- 0.03) and flavonoids (64.33 +/- 0.35) in the chloroform; and polysaccharides in the ethanol (268.75 +/- 0.34), and glycosaponins (78.01 +/- 0.07) in the methanol. The chloroform extract exhibited maximum antidiabetic potential, showing inhibition of nonenzymatic glycosylation of hemoglobin (65%), and alpha-amylase inhibition (32%) with maximum percent glucose uptake by the ethanol extract (78%). Only the ethanol extract had dose-dependent cytotoxic potential against the HepG2 cells. After 24-h exposure to the ethanol-extract, the expression of protein kinase B (Akt) remained unchanged, while the expression of B-cell lymphoma 2 (BCL2) and BCL2 associated X (BAX) changed significantly. After 48-h exposure, the expression of Akt decreased significantly, while that of BCL2 and BAX increased significantly. Olea ferruginea R bark possessed in vitro antidiabetic potential and anticancer/cytotoxic effects, attributable to the decline in the prosurvival signals of the Akt signaling pathway.

Keywords:

Olea ferruginea R cytotoxicity, MTT, Akt, BAD, antidiabetic,

PDF

___

Ademiluyi AO, 2013, EXP TOXICOL PATHOL, V65, P305, DOI 10.1016/j.etp.2011.09.005
Adisa RA, 2004, J CAMEROON ACAD SCI, V4, P351
Ahmad A, 2014, PAK J PHARM SCI, V27, P1175
Ahmad KR, 2016, FLUORIDE, V49, P112 .
Ahmad M, 2009, PAK J BOT, V41, P2777 .
Ahmed A, 2016, PAK J PHARM SCI, V29, P2065
Ahmed M., 2015, Journal of Plant Breeding and Crop Science, V7, P158
Ahmed M, 2009, PAK J BOT, V41, P2683 .
Al-Hooti S, 1998, J FOOD SCI TECH MYS, V35, P44
Ashraf U, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8080722
Ayeni M. J., 2015, Journal of Natural Sciences Research, V5, P99
Bahadar H, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0117-y
Besbes S, 2004, FOOD CHEM, V84, P577, DOI 10.1016/S0308-8146(03)00281-4
Besnard G, 2002, ACTA BOT GALLICA, V149, P49, DOI 10.1080/12538078.2002.10515928
Bhutkar Mangesh, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P866, DOI 10.1016/S2221-1691(13)60170-7
Caltana L, 2014, NEUROCHEM INT, V79, P79, DOI 10.1016/j.neuint.2014.09.011
Calvo E, 2009, ONCOTARGETS THER, V2, P135
Chang CC, 2002, J FOOD DRUG ANAL, V10, P178
Dembinska-Kiec A, 2008, BRIT J NUTR, V99, pES109, DOI 10.1017/S000711450896579X
Elosta A, 2012, CURR DIABETES REV, V8, P92, DOI 10.2174/157339912799424528
Fabricant DS, 2001, ENVIRON HEALTH PERSP, V109, P69, DOI 10.2307/3434847
Farnsworth NR, 1988, BIODIVERSITY, P81 .
Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688
Gavamukulya Y, 2014, ASIAN PAC J TROP MED, V7, pS355, DOI 10.1016/S1995-7645(14)60258-3
Gewali MB, 2008, ASPECTS TRADITIONAL .
Greenwell M, 2015, INT J PHARM SCI RES, V6, P4103, DOI 10.13040/IJPSR.0975-8232.6(10).4103-12
Gu-Joong Kwon, 2007, [Korean Journal of Food Science and Technology, 한국식품과학회지], V39, P569
Hashmi MA, 2015, REC NAT PROD, V9, P164 .
Hashmi MA, 2014, SPECTROCHIM ACTA A, V128, P225, DOI 10.1016/j.saa.2014.02.163
Hussain K, 2008, NATURAL PRODUCT RADI, V7, P402
Hussain W, 2018, AVICENNA J PHYTOMEDI, V8, P313
Jemai H, 2009, J AGR FOOD CHEM, V57, P8798, DOI 10.1021/jf901280r
Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200
Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009
LOWRY OH, 1951, J BIOL CHEM, V193, P265 .
Malviya N, 2010, ACTA POL PHARM, V67, P113
Mehmood A, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2239-0
Meng Y, 2017, EXP THER MED, V13, P2417, DOI 10.3892/etm.2017.4259
MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
Pandita D, 2014, INT J INDIGENOUS MED, V47, P1603
PARKER KM, 1981, CLIN CHEM, V27, P669 .
Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975
Saeed H, 2011, J BONE MINER RES, V26, P1494, DOI 10.1002/jbmr.349
Saleem B, 2018, BRAZ J PHARM SCI, V54, DOI 10.1590/s2175-97902018000217467
Shah SA, 2016, J ETHNOPHARMACOL, V182, P67, DOI 10.1016/j.jep.2016.02.008
Sharma RK, 2013, INT J BIOSCIENCE BIO, V3, P154, DOI [10.7763/IJBBB.2013.V3.185, DOI 10.7763/IJBBB.2013.V3.185]
Shinwari ZK, 2010, J MED PLANTS RES, V4, P161
Shinwari ZK, 2011, PAK J BOT, V43, P5 .
SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49
Snyder RW, 2004, SEMIN DIALYSIS, V17, P365, DOI 10.1111/j.0894-0959.2004.17346.x
Solayman M, 2016, CURR PHARM DESIGN, V22, P549, DOI 10.2174/1381612822666151125001111
Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241
Sultana N, 2008, J ENZYM INHIB MED CH, V23, P739, DOI [10.1080/14756360701633187, 10.1080/14756360701633187 ]
Wu CH, 2011, FOOD FUNCT, V2, P224, DOI 10.1039/c1fo10026b
Xiao JB, 2015, CURR MED CHEM, V22, P23 .
Xu H, 2016, J ONCOLOGY RES TREAT, V1, P2
Yeh WJ, 2017, J FOOD DRUG ANAL, V25, P84, DOI 10.1016/j.jfda.2016.10.017
Yusuf A, 2013, JPN J CLIN ONCOL, V43, P771, DOI 10.1093/jjco/hyt078
Zafar S, 2019, J ASIAN NAT PROD RES, V21, P679, DOI 10.1080/10286020.2018.1467894
Zong AZ, 2012, CARBOHYD POLYM, V90, P1395, DOI 10.1016/j.carbpol.2012.07.026